• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Option Care Health Announces Preliminary Financial Results for Fourth Quarter and Full Year 2024 and Preliminary Financial Expectations for Full Year 2025

    1/13/25 7:05:00 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care
    Get the next $OPCH alert in real time by email

    BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2024.

    For the fourth quarter 2024, Option Care Health expects to report:

    • Net revenue of approximately $1.34 billion to $1.35 billion, representing approximately 19.2% to 20.1% growth over the fourth quarter of 2023
    • Net income of approximately $56.8 to $60.9 million, or diluted earnings per share of $0.33 to $0.36
    • Adjusted net income of approximately $71.0 million to $76.8 million, or adjusted diluted earnings per share of $0.42 to $0.45
    • Adjusted EBITDA of approximately $118.7 million to $121.7 million, representing approximately a 6.4% to 9.1% increase over the fourth quarter of 2023

    For full year 2024, Option Care Health expects to report:

    • Net revenue of approximately $4.99 billion to $5.00 billion, representing approximately 16.0% to 16.2% growth over the prior year
    • Net income of approximately $208.5 million to $212.6 million, or diluted earnings per share of $1.21 to $1.23
    • Adjusted net income of approximately $268.3 million to $274.1 million, or adjusted diluted earnings per share of $1.55 to $1.59
    • Adjusted EBITDA of approximately $441.0 million to $444.0 million, representing approximately a 3.7% to 4.4% increase over the prior year
    • Cash flow from operations of at least $300 million
    • Cash and cash equivalents of approximately $412.6 million

    Preliminary Full Year 2025 Guidance

    For the full year 2025, Option Care Health expects to deliver the following financial results:

    • Net revenue of $5.2 billion to $5.4 billion
    • Adjusted EBITDA of $445 million to $465 million
    • Adjusted EPS of $1.59 to $1.69

    This preliminary guidance incorporates a negative gross profit impact of approximately $60 million to $70 million dollars related to the Stelara pricing adjustments discussed on the Company's third quarter earnings call. The Company expects to provide further information regarding its full year 2025 financial guidance on its fourth quarter earnings call in February.

    New Share Repurchase Program Authorization

    In the fourth quarter of 2024, the Company completed the remaining $90 million of share repurchases under its prior share repurchase program. On January 10, 2025, the Company's Board of Directors approved a new $500 million stock repurchase program. This program has no specified expiration date. Shares may be repurchased under the program through open market purchases, privately negotiated transactions, block trades, or accelerated or other structured share repurchase programs. The extent to which the Company repurchases shares, and the timing of such repurchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other corporate considerations, as determined by the Company's management.

    Investor Conference Presentation

    The Company will be participating in the 43rd Annual J.P. Morgan Healthcare Conference, including a Company presentation at 1:30 p.m. P.T. on Monday, January 13, 2025. The presentation, including the presentation materials, can be accessed via live audio webcast that will be available online at investors.optioncarehealth.com.

    Conference Call

    The Company expects to release its full fourth quarter and full year results on Wednesday, February 26, 2025 before the market opens and host a conference call to review the results at 8:30 a.m. E.T. on the same day.

    The conference call can be accessed via a live audio webcast that will be available online at investors.optioncarehealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

    About Option Care Health

    Option Care Health is the nation's largest independent provider of home and alternate site infusion services. With over 8,000 team members, including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and teammates. To learn more, please visit our website at optioncarehealth.com.

    Investor Contacts

    Mike Shapiro

    Chief Financial Officer

    T: (312) 940-2538

    [email protected]

    Forward-Looking Statements - Safe Harbor

    This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "project," "estimate," "expect," "may," "should," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements the Company may make regarding future revenues, future earnings, other future financial results, regulatory developments, market developments, new products and growth strategies and the effects of any of the foregoing on its future results of operations or financial condition.

    Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. The Company's actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: changes in laws and regulations applicable to its business model; changes in market conditions and receptivity to its services and offerings; pending and future litigation; potential liability for claims not covered by insurance; and loss of relationships with managed care organizations and other non-governmental third party payers. For a detailed discussion of the risk factors that could affect its actual results, please refer to the risk factors identified in the Company's SEC reports as filed with the SEC.

    Any forward-looking statement made by the Company in this press release is based only on information currently available to it and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

    Preliminary Unaudited Financial Data

    The preliminary financial information included in this press release is subject to completion of the Company's year-end close procedures and further financial review. The Company has provided ranges, rather than specific amounts, because these results are preliminary and subject to change. Actual results may differ from these estimates as a result of the completion of the Company's year-end closing procedures, review adjustments and other developments that may arise between now and the time such financial information for the period is finalized. As a result, these estimates are preliminary, may change and constitute forward-looking information and, as a result, are subject to risks and uncertainties. These preliminary estimates should not be viewed as a substitute for full financial statements prepared in accordance with United States generally accepted accounting principles ("GAAP"), and they should not be viewed as indicative of the Company's results for any future period. The Company's independent registered public accounting firm has not audited, reviewed, compiled, or performed any procedures with respect to these estimated financial results and, accordingly, does not express an opinion or any other form of assurance with respect to these preliminary estimates.

    Note Regarding Use of Non-GAAP Financial Measures

    In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted net income, Adjusted EBITDA and Adjusted earnings per share ("Adjusted EPS"), which are non-GAAP financial measures. These adjusted measures are not measurements of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, earnings per share, or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of the Company's liquidity. In addition, the Company's definitions of Adjusted net income, Adjusted EBITDA, and Adjusted EPS may not be comparable to similarly titled non-GAAP financial measures reported by other companies. As defined by the Company: (i) Adjusted net income represents net income before intangible asset amortization expense, stock-based compensation expense, and restructuring, acquisition, integration and other expenses, net of tax adjustments, (ii) Adjusted EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, and (iii) Adjusted earnings per share represents Adjusted net income divided by weighted average common shares outstanding, diluted. As part of restructuring, acquisition, integration and other expenses, the Company may incur significant charges such as the write down of certain long‑lived assets, temporary redundant expenses, professional fees, certain litigation expenses and reserves related to acquired businesses, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that these adjusted measures provide useful supplemental information regarding the performance of Option Care Health's business operations and facilitate comparisons to the Company's historical operating results. The Company has not reconciled Adjusted EBITDA guidance to net income, nor Adjusted EPS guidance to GAAP earnings per share, as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items. Full reconciliations of each adjusted measure to the most comparable GAAP financial measure are set forth below.

        
    OPTION CARE HEALTH, INC.

    RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES

    (IN MILLIONS, EXCEPT PER SHARE AMOUNTS)

    (UNAUDITED)
        
        
     Three Months Ended

    December 31, 2024
     Full Year Ended

    December 31, 2024
     Low High Low High
    Net income$56.8  $60.9  $208.5  $212.6 
    Interest expense, net 10.9   10.9   49.0   49.0 
    Income tax expense 22.3   20.0   73.2   70.9 
    Depreciation and amortization expense 17.5   17.5   63.5   63.5 
    EBITDA 107.5   109.3   394.2   396.0 
            
    EBITDA adjustments       
    Stock-based incentive compensation 8.5   8.5   36.1   36.1 
    Loss on extinguishment of debt —   —   0.4   0.4 
    Restructuring, acquisition, integration and other 2.8   4.0   10.3   11.5 
    Adjusted EBITDA$118.7  $121.7  $441.0  $444.0 
            
    Net income$56.8  $60.9  $208.5  $212.6 
    Intangible asset amortization expense 8.6   8.6   34.4   34.4 
    Stock-based incentive compensation 8.5   8.5   36.1   36.1 
    Restructuring, acquisition, integration and other 2.8   4.0   10.3   11.5 
    Total pre-tax adjustments 19.9   21.1   80.8   82.0 
    Tax adjustments (1) (5.7)  (5.2)  (21.0)  (20.5)
    Adjusted net income$71.0  $76.8  $268.3  $274.1 
            
    Earnings per share, diluted$0.33  $0.36  $1.21  $1.23 
    Adjusted earnings per share, diluted$0.42  $0.45  $1.55  $1.59 
    Weighted average common shares outstanding, diluted 169,980   169,980   172,845   172,845 
                    

    (1) Tax adjustments for fourth quarter and full year 2024 includes the estimated income tax effect on non-GAAP adjustments based on the expected effective tax rate



    Get the next $OPCH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OPCH

    DatePrice TargetRatingAnalyst
    4/30/2025$40.00Neutral → Buy
    UBS
    1/23/2025$26.00 → $35.00Hold → Buy
    Jefferies
    1/13/2025$26.00 → $33.00Neutral → Buy
    BofA Securities
    12/5/2024$26.00Neutral
    UBS
    11/4/2024$27.00Buy → Neutral
    Goldman
    10/31/2024$38.00 → $26.00Buy → Hold
    Jefferies
    10/30/2024$43.00 → $29.00Buy → Neutral
    BofA Securities
    7/16/2024$36.00Mkt Outperform
    JMP Securities
    More analyst ratings

    $OPCH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Option Care Health to Participate in Upcoming Investor Conferences

      BANNOCKBURN, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: The Bank of America Healthcare Conference, being held in Las Vegas, on Tuesday, May 13, 2025, including a presentation at 8:00am PT/11:00am ET.The William Blair 45th Annual Growth Stock Conference, being held in Chicago, on Tuesday, June 3, 2025, including a presentation at 11:20am CT/12:20pm ET.The Goldman Sachs 46th Annual Global Healthcare Conference, being held in Miami, on Monday, June 9, 2025, including a fireside chat

      5/1/25 4:05:00 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2025

      BANNOCKBURN, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenue of $1,333.0 million, up 16.3% compared to $1,146.1 million in the first quarter of 2024Gross profit of $263.1 million, or 19.7% of net revenue, up 10.3% compared to $238.5 million, or 20.8% of net revenue, in the first quarter of 2024Net income of $46.7 million, compared to net income of $44.8 million, in the first quarter of 2024 and diluted

      4/29/25 7:00:00 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health to Announce First Quarter 2025 Financial Results and Host Conference Call

      BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2025 on Tuesday, April 29, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI29e3b2a044544585b1ab833b09a90572. The call can also be accessed via a liv

      3/24/25 4:05:00 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Financials

    Live finance-specific insights

    See more
    • Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2025

      BANNOCKBURN, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenue of $1,333.0 million, up 16.3% compared to $1,146.1 million in the first quarter of 2024Gross profit of $263.1 million, or 19.7% of net revenue, up 10.3% compared to $238.5 million, or 20.8% of net revenue, in the first quarter of 2024Net income of $46.7 million, compared to net income of $44.8 million, in the first quarter of 2024 and diluted

      4/29/25 7:00:00 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health to Announce First Quarter 2025 Financial Results and Host Conference Call

      BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2025 on Tuesday, April 29, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI29e3b2a044544585b1ab833b09a90572. The call can also be accessed via a liv

      3/24/25 4:05:00 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2024

      BANNOCKBURN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Net revenue of $1,346.4 million, up 19.7% compared to $1,124.4 million in the fourth quarter of 2023Gross profit of $268.4 million, or 19.9% of net revenue, up 8.6% compared to $247.1 million, or 22.0% of net revenue, in the fourth quarter of 2023Net income of $60.1 million, compared to net income of $57.2 million, in the fourth quarter

      2/26/25 7:00:00 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Option Care Health upgraded by UBS with a new price target

      UBS upgraded Option Care Health from Neutral to Buy and set a new price target of $40.00

      4/30/25 7:24:45 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health upgraded by Jefferies with a new price target

      Jefferies upgraded Option Care Health from Hold to Buy and set a new price target of $35.00 from $26.00 previously

      1/23/25 7:51:53 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health upgraded by BofA Securities with a new price target

      BofA Securities upgraded Option Care Health from Neutral to Buy and set a new price target of $33.00 from $26.00 previously

      1/13/25 12:17:48 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Medical Officer Adewunmi Femi covered exercise/tax liability with 1,396 shares, decreasing direct ownership by 7% to 18,758 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      4/24/25 5:01:23 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Chief Human Resources Officer Bavaro Michael exercised 14,739 shares at a strike of $25.43 and sold $1,030,843 worth of shares (30,996 units at $33.26), decreasing direct ownership by 27% to 44,974 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      3/3/25 5:52:17 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Rademacher John Charles was granted 74,814 shares, increasing direct ownership by 11% to 752,181 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      2/26/25 7:40:41 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Option Care Health Inc.

      SC 13G - Option Care Health, Inc. (0001014739) (Subject)

      11/8/24 10:46:38 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Option Care Health Inc. (Amendment)

      SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)

      2/13/24 5:12:03 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Option Care Health Inc. (Amendment)

      SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)

      9/11/23 1:33:44 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Leadership Updates

    Live Leadership Updates

    See more
    • NorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers

      NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, today announced the appointment of Barbara W. Bodem and David Keeling to its Board of Managers, effective February 12, 2024. Following these appointments, the Board will comprise of 8 directors, 5 of whom are non-executive. "We are pleased to welcome Barbara and David to the NorthStar Board," said Stephen Merrick, Executive Chairman of NorthStar. "Barbara's deep experience serving in senior finance and board roles in leading edge pharmaceutical and

      2/27/24 9:00:00 AM ET
      $BMRN
      $ENOV
      $OPCH
      $SYNH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Industrial Specialties
      Medical/Nursing Services
    • Riverbed|Aternity Announces Appointment of New Board of Directors

      New Board Brings Significant and Diverse Experience to Support Company's Growth and Success Riverbed|Aternity (the "Company") today announced that, as part of its recapitalization, which was finalized today, the following seven directors have been appointed to the Company's new Board of Directors (the "Board"). These appointments became effective on December 7, 2021, upon the completion of the Company's recapitalization and voluntary court-supervised process. "We are pleased to welcome our new directors, a group of seasoned, accomplished and respected business leaders who will bring a wide and diverse range of skills to the Riverbed|Aternity Board," said Dan Smoot, President and CEO of Ri

      12/7/21 6:32:00 PM ET
      $MODV
      $OPCH
      Transportation Services
      Consumer Discretionary
      Medical/Nursing Services
      Health Care
    • Option Care Health Appoints Dr. Seema Kumbhat to the Position of Chief Medical Officer

      BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health")(NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer. In this newly created role, Dr. Kumbhat will oversee all clinical strategies for the Company, including clinical operations, continuous quality improvement, accreditation, clinically related sales and marketing efforts, and adherence to regulatory requirements. Dr. Kumbhat will also focus on optimizing clinical operations to ensure the Company delivers the highest quality standards, supe

      7/28/21 9:00:00 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    SEC Filings

    See more
    • SEC Form 10-Q filed by Option Care Health Inc.

      10-Q - Option Care Health, Inc. (0001014739) (Filer)

      4/29/25 4:00:41 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Option Care Health, Inc. (0001014739) (Filer)

      4/29/25 6:57:02 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • SEC Form DEFA14A filed by Option Care Health Inc.

      DEFA14A - Option Care Health, Inc. (0001014739) (Filer)

      4/2/25 4:06:47 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kraemer Harry M Jansen Jr bought $969,031 worth of shares (43,000 units at $22.54), increasing direct ownership by 15% to 326,334 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      11/13/24 5:27:03 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Kraemer Harry M Jansen Jr bought $1,104,352 worth of shares (35,000 units at $31.55), increasing direct ownership by 15% to 269,528 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      2/28/24 4:41:59 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Bierbower Elizabeth D bought $79,110 worth of shares (3,000 units at $26.37), increasing direct ownership by 29% to 13,515 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      11/1/23 5:09:51 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care